228 related articles for article (PubMed ID: 23772227)
1. Therapeutic role of hematopoietic stem cells in autism spectrum disorder-related inflammation.
Siniscalco D; Bradstreet JJ; Antonucci N
Front Immunol; 2013; 4():140. PubMed ID: 23772227
[TBL] [Abstract][Full Text] [Related]
2. Possible use of Trichuris suis ova in autism spectrum disorders therapy.
Siniscalco D; Antonucci N
Med Hypotheses; 2013 Jul; 81(1):1-4. PubMed ID: 23597946
[TBL] [Abstract][Full Text] [Related]
3. Involvement of dietary bioactive proteins and peptides in autism spectrum disorders.
Siniscalco D; Antonucci N
Curr Protein Pept Sci; 2013 Dec; 14(8):674-9. PubMed ID: 24106964
[TBL] [Abstract][Full Text] [Related]
4. Mesenchymal stem cells in treating autism: Novel insights.
Siniscalco D; Bradstreet JJ; Sych N; Antonucci N
World J Stem Cells; 2014 Apr; 6(2):173-8. PubMed ID: 24772244
[TBL] [Abstract][Full Text] [Related]
5. Inflammation and Neuro-Immune Dysregulations in Autism Spectrum Disorders.
Siniscalco D; Schultz S; Brigida AL; Antonucci N
Pharmaceuticals (Basel); 2018 Jun; 11(2):. PubMed ID: 29867038
[TBL] [Abstract][Full Text] [Related]
6. Perspectives on the use of stem cells for autism treatment.
Siniscalco D; Bradstreet JJ; Sych N; Antonucci N
Stem Cells Int; 2013; 2013():262438. PubMed ID: 24222772
[TBL] [Abstract][Full Text] [Related]
7. Inflammation and Mitochondrial Dysfunction in Autism Spectrum Disorder.
Gevezova M; Sarafian V; Anderson G; Maes M
CNS Neurol Disord Drug Targets; 2020; 19(5):320-333. PubMed ID: 32600237
[TBL] [Abstract][Full Text] [Related]
8. Pharmaceuticals and Stem Cells in Autism Spectrum Disorders: Wishful Thinking?
Sivanesan S; Tan A; Jeyaraj R; Lam J; Gole M; Hardan A; Ashkan K; Rajadas J
World Neurosurg; 2017 Feb; 98():659-672. PubMed ID: 27725300
[TBL] [Abstract][Full Text] [Related]
9. The autism spectrum phenotype in ADNP syndrome.
Arnett AB; Rhoads CL; Hoekzema K; Turner TN; Gerdts J; Wallace AS; Bedrosian-Sermone S; Eichler EE; Bernier RA
Autism Res; 2018 Sep; 11(9):1300-1310. PubMed ID: 30107084
[TBL] [Abstract][Full Text] [Related]
10. Stem cell therapy in autism: recent insights.
Siniscalco D; Kannan S; Semprún-Hernández N; Eshraghi AA; Brigida AL; Antonucci N
Stem Cells Cloning; 2018; 11():55-67. PubMed ID: 30425534
[TBL] [Abstract][Full Text] [Related]
11. Biomarker-guided interventions of clinically relevant conditions associated with autism spectrum disorders and attention deficit hyperactivity disorder.
Bradstreet JJ; Smith S; Baral M; Rossignol DA
Altern Med Rev; 2010 Apr; 15(1):15-32. PubMed ID: 20359266
[TBL] [Abstract][Full Text] [Related]
12. Prevalence of autism spectrum disorders--Autism and Developmental Disabilities Monitoring Network, 14 sites, United States, 2008.
;
MMWR Surveill Summ; 2012 Mar; 61(3):1-19. PubMed ID: 22456193
[TBL] [Abstract][Full Text] [Related]
13. Rational use of mesenchymal stem cells in the treatment of autism spectrum disorders.
Liu Q; Chen MX; Sun L; Wallis CU; Zhou JS; Ao LJ; Li Q; Sham PC
World J Stem Cells; 2019 Feb; 11(2):55-72. PubMed ID: 30842805
[TBL] [Abstract][Full Text] [Related]
14. Epigenetic findings in autism: new perspectives for therapy.
Siniscalco D; Cirillo A; Bradstreet JJ; Antonucci N
Int J Environ Res Public Health; 2013 Sep; 10(9):4261-73. PubMed ID: 24030655
[TBL] [Abstract][Full Text] [Related]
15. Possible Effect of the use of Mesenchymal Stromal Cells in the Treatment of Autism Spectrum Disorders: A Review.
Tamouza R; Volt F; Richard JR; Wu CL; Bouassida J; Boukouaci W; Lansiaux P; Cappelli B; Scigliuolo GM; Rafii H; Kenzey C; Mezouad E; Naamoune S; Chami L; Lejuste F; Farge D; Gluckman E
Front Cell Dev Biol; 2022; 10():809686. PubMed ID: 35865626
[TBL] [Abstract][Full Text] [Related]
16. Plasma peroxiredoxin changes and inflammatory cytokines support the involvement of neuro-inflammation and oxidative stress in Autism Spectrum Disorder.
Abruzzo PM; Matté A; Bolotta A; Federti E; Ghezzo A; Guarnieri T; Marini M; Posar A; Siciliano A; De Franceschi L; Visconti P
J Transl Med; 2019 Oct; 17(1):332. PubMed ID: 31578139
[TBL] [Abstract][Full Text] [Related]
17. Cytokine expression profiles in Autism spectrum disorder: A multi-center study from Turkey.
Kutuk MO; Tufan E; Gokcen C; Kilicaslan F; Karadag M; Mutluer T; Yektas C; Coban N; Kandemir H; Buber A; Coskun S; Acikbas U; Guler G; Topal Z; Celik F; Altintas E; Giray A; Aka Y; Kutuk O
Cytokine; 2020 Sep; 133():155152. PubMed ID: 32563959
[TBL] [Abstract][Full Text] [Related]
18. Autism spectrum disorders: is mesenchymal stem cell personalized therapy the future?
Siniscalco D; Sapone A; Cirillo A; Giordano C; Maione S; Antonucci N
J Biomed Biotechnol; 2012; 2012():480289. PubMed ID: 22496609
[TBL] [Abstract][Full Text] [Related]
19. Neuro-Inflammatory Mechanisms in Developmental Disorders Associated with Intellectual Disability and Autism Spectrum Disorder: A Neuro- Immune Perspective.
Di Marco B; Bonaccorso CM; Aloisi E; D'Antoni S; Catania MV
CNS Neurol Disord Drug Targets; 2016; 15(4):448-63. PubMed ID: 26996174
[TBL] [Abstract][Full Text] [Related]
20. Variation in Gene Expression in Autism Spectrum Disorders: An Extensive Review of Transcriptomic Studies.
Ansel A; Rosenzweig JP; Zisman PD; Melamed M; Gesundheit B
Front Neurosci; 2016; 10():601. PubMed ID: 28105001
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
